Grandeur Peak Global Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,588
Closed -$65K 137
2024
Q2
$65K Sell
16,588
-234,155
-93% -$1.01M 0.01% 131
2024
Q1
$1.05M Sell
250,743
-406,173
-62% -$1.91M 0.08% 99
2023
Q4
$3.09M Sell
656,916
-777,903
-54% -$3.03M 0.22% 77
2023
Q3
$4.48M Buy
1,434,819
+56,271
+4% +$226K 0.34% 57
2023
Q2
$6.33M Buy
1,378,548
+189,064
+16% +$869K 0.43% 50
2023
Q1
$5.89M Sell
1,189,484
-2,321
-0.2% -$11.4K 0.36% 49
2022
Q4
$6.51M Sell
1,191,805
-14,208
-1% -$87.1K 0.39% 44
2022
Q3
$7.84M Buy
1,206,013
+23,997
+2% +$134K 0.48% 42
2022
Q2
$5.59M Buy
1,182,016
+680,205
+136% +$3.35M 0.35% 52
2022
Q1
$3.51M Buy
501,811
+260,434
+108% +$1.78M 0.17% 78
2021
Q4
$2.46M Buy
241,377
+86,452
+56% +$928K 0.11% 87
2021
Q3
$1.89M Buy
+154,925
New +$2.34M 0.09% 90

Other funds holding MXCT

Grandeur Peak Global Advisors's MXCT Position: Q3 2024 in Review

Grandeur Peak Global Advisors sold out of MaxCyte (MXCT) in Q3 2024, closing a stake of 16,588 shares — an estimated $65K sold.

Grandeur Peak Global Advisors first reported a position in MXCT in Q3 2021 and held it in 12 quarters. The position peaked at $7.84M in Q3 2022. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2024.

  • Grandeur Peak Global Advisors reported no remaining MaxCyte position as of Q3 2024 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 16,588 MaxCyte shares in Q3 2024, an estimated $65K.
  • Grandeur Peak Global Advisors first reported a position in MaxCyte in Q3 2021 and held it in 12 quarters.
  • Grandeur Peak Global Advisors's MaxCyte position peaked at $7.84M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2024.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.